What it's for (Indications)
- This tripartite topical medication is indicated for the treatment of inflammatory dermatoses that are responsive to corticosteroids, when these conditions are complicated by secondary infections caused by fungi (dermatophytes, yeasts, molds) and/or bacteria (susceptible to gentamicin).
- Specific conditions may include inflammatory tinea corporis, tinea cruris, and tinea pedis, where both fungal and bacterial components contribute to the clinical presentation, alongside significant inflammation and pruritus.
- It is particularly useful when the inflammation is prominent and the presence of both fungal and bacterial pathogens is clinically suspected or confirmed, necessitating a broad-spectrum approach to manage the various etiologies simultaneously.
- The corticosteroid component alleviates inflammation, itching, and redness, while the antifungal and antibacterial agents address the respective infectious components.
- This combination aims to provide comprehensive management for complex skin infections that would otherwise require multiple separate agents.
- Its use should be reserved for cases where the benefits of combining these agents outweigh the potential risks, typically for short-term management of acute exacerbations.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults and pediatric patients above 12 years of age, a thin layer of the ointment should be gently applied to the affected skin areas twice daily, typically in the morning and evening. The duration of treatment should be kept as short as possible, generally not exceeding two to four weeks, depending on the severity and nature of the condition, and response to therapy. Application should be limited to the smallest effective amount and surface area to minimize potential systemic absorption and adverse effects, especially for the corticosteroid and antibiotic components. Occlusive dressings should generally be avoided unless specifically instructed by a healthcare professional due to the increased risk of systemic absorption and local adverse reactions, including skin atrophy and potentiation of bacterial/fungal growth. Treatment should be re-evaluated if no improvement is seen after one week, and continued use beyond the recommended duration should be critically assessed by a physician to prevent long-term complications and antimicrobial resistance development. This product is for external use only. |
Safety & Warnings
Common Side Effects
- The use of this combination product can lead to various local and, less commonly, systemic side effects.
- Common local reactions attributed to the corticosteroid include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
- Clotrimazole may cause localized burning, stinging, erythema, edema, pruritus, urticaria, and general skin irritation.
- Gentamicin can cause transient irritation, itching, burning, and erythema at the application site, as well as allergic contact dermatitis.
- With prolonged use, extensive application, or application under occlusion, systemic absorption of betamethasone can lead to hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria.
- Although rare with topical use, significant systemic absorption of gentamicin, particularly through damaged skin, large surface areas, or prolonged use, carries a theoretical risk of ototoxicity (hearing impairment, vestibular dysfunction) and nephrotoxicity (kidney damage), especially in susceptible individuals or those with compromised renal function.
- If any severe local or systemic reactions occur, discontinue use and consult a physician.
Serious Warnings
- Black Box Warning: While specific FDA-style 'Black Box Warnings' are not typically issued for topical preparations of betamethasone dipropionate, clotrimazole, or gentamicin individually, nor for this specific combination product, it is imperative to include a **Serious Warnings** section due to the potential for significant adverse outcomes, particularly with inappropriate, prolonged, or extensive use. The presence of **gentamicin**, an aminoglycoside antibiotic, carries a theoretical risk of systemic ototoxicity (permanent hearing loss and/or vestibular damage) and nephrotoxicity (kidney damage) if sufficient quantities are absorbed systemically. This risk, though generally low for topical application on intact skin for short durations, is significantly increased when applied to large body surface areas, to broken or damaged skin, under occlusive dressings, or for prolonged durations, especially in patients with pre-existing renal impairment, concomitant use of other ototoxic/nephrotoxic medications, or in neonates/infants. Furthermore, the potent corticosteroid **betamethasone dipropionate** can lead to significant hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and growth retardation in children, particularly with extensive or prolonged use, or use under occlusion. These serious systemic effects underscore the critical need for careful patient selection, strict adherence to prescribed dosage and duration, and vigilant monitoring for signs of systemic absorption or adverse reactions, especially in vulnerable populations. The indiscriminate or prolonged use of the gentamicin component can also foster the development of antimicrobial resistance, rendering future bacterial infections more difficult to treat. Patients must be counselled on the severe risks associated with misuse and the importance of using this potent combination strictly as prescribed by a qualified healthcare professional.
- This medication should be used with extreme caution, particularly in infants, children, and on the face, groin, or axillae due to the enhanced systemic absorption and increased risk of local adverse effects such as skin atrophy and HPA axis suppression.
- Prolonged or widespread use, especially under occlusive dressings, should be avoided as it significantly increases the risk of corticosteroid-related systemic effects.
- The gentamicin component carries a risk of promoting bacterial resistance if used indiscriminately or for extended periods; therefore, bacterial susceptibility should be confirmed where possible.
- Cross-resistance to other aminoglycoside antibiotics may occur.
- The antifungal component, clotrimazole, while generally well-tolerated, may mask the underlying infection if used improperly.
- Discontinue treatment if irritation, sensitization, or superinfection develops.
- Avoid contact with eyes, mucous membranes, and open wounds.
- Not intended for ophthalmic use.
- Close monitoring is crucial for any signs of systemic absorption or adverse reactions during the course of therapy.
- This product is not recommended for rosacea or perioral dermatitis, as corticosteroids can exacerbate these conditions.
- Use in pregnancy and lactation only if clearly needed and the potential benefits justify the potential risks, with physician consultation.
How it Works (Mechanism of Action)
This topical formulation combines three active pharmaceutical ingredients, each with a distinct mechanism of action to address complex dermatological conditions. **Betamethasone dipropionate** is a potent synthetic corticosteroid that exerts its anti-inflammatory, antipruritic, and vasoconstrictive effects by inducing phospholipase A2 inhibitory proteins, called lipocortins. These proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. This action reduces capillary permeability, leukocyte migration, and prostaglandin synthesis, thereby alleviating inflammation, erythema, and pruritus. **Clotrimazole** is an imidazole antifungal agent that primarily inhibits the biosynthesis of ergosterol, a crucial component of fungal cell membranes. This inhibition leads to structural and functional impairment of the fungal cytoplasmic membrane, resulting in altered membrane permeability and eventually fungal cell death. It is effective against a broad spectrum of dermatophytes, yeasts, and molds. **Gentamicin sulfate** is an aminoglycoside antibiotic that binds to the 30S subunit of the bacterial ribosome, thereby inhibiting bacterial protein synthesis. This ultimately disrupts the bacterial cell's ability to produce essential proteins, leading to bactericidal action against a wide range of susceptible Gram-negative and some Gram-positive bacteria, effectively combating bacterial co-infections. The synergistic action of these three agents targets the multi-etiological nature of complicated inflammatory dermatoses.
Commercial Brands (Alternatives)
No other brands found for this formula.